Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant TreatmentArticle Published on 2022-12-092023-07-10 Journal: The oncologist [Category] COVID19(2023년), [키워드] adjuvant chemotherapy anti-spike antibody breast cancer. COVID-19 SARS-CoV-2 vaccines [DOI] 10.1093/oncolo/oyac196 PMC 바로가기
Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical managementArticle Published on 2022-12-012022-11-16 Journal: Endocrine [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] adjuvant adverse effects age Autoimmune autoimmune thyroiditis benefit Clinical management clinician described disease Diseases Doppler Factor Fever Follow-up Genetic genetic susceptibility grave Graves’ disease homology inactivated Inflammatory inflammatory markers men molecular mRNA-based Neck pain palpitation pandemic pathogenic mechanism Patient patients patients with SARS-CoV-2 predisposition Protein reported SARS-CoV-2 SARS-CoV-2 protein SARS-CoV-2 vaccination SARS-CoV-2 vaccines silent Subacute Subacute thyroiditis symptoms onset syndrome Thyroid Thyroiditis Treatment vaccination Vaccine Vaccines. women [DOI] 10.1007/s12020-022-03118-4 PMC 바로가기
Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variantsArticle Published on 2022-12-012022-11-15 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] addition adenoviral vector Adenovirus adenovirus type 5 vector vaccine Anti-RBD IgG booster COVID-19 COVID-19 vaccine D614G demonstrated dose effective Efficacy IgA immunization Inactivated vaccine Inactivated Vaccines Inhaled lack mucosal Neutralization assay Neutralizing neutralizing antibody omicron Omicron variant BA.5 pandemic plasma Protective RBD SARS-CoV-2 SARS-CoV-2 pseudovirus SARS-CoV-2 vaccines SARS-CoV-2 variant subunit titre Vaccination strategies vaccination strategies. Vaccination strategy Vaccine variant virus widespread [DOI] 10.1080/22221751.2022.2132881 PMC 바로가기
Distinct immune responses in the early phase to natural SARS-CoV-2 infection or vaccinationArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 진단, [키워드] acute phase acute respiratory syndrome analyzed antibody Antibody Response coronavirus cytokine cytokine expression cytokine level Cytokines dose early phase elicited expression healthy IgA antibody immune response immunization implication inactivated Inactivated vaccine Inactivated Vaccines infected individuals natural infection nucleocapsid postvaccination Protein Reinfection response SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike SARS-CoV-2 vaccine SARS-CoV-2 vaccines serological significant differences two groups vaccination vaccination. Vaccines variety viral infection [DOI] 10.1002/jmv.28034 PMC 바로가기
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccineesArticle Published on 2022-11-302023-07-10 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), [키워드] Hybrid immunity mRNA booster neutralizing antibodies. Omicron BA.1 Omicron BA.2 SARS-CoV-2 SARS-CoV-2 vaccines [DOI] 10.1080/21645515.2022.2129196 PMC 바로가기
Evaluation of the efficacy of four anti-SARS-CoV-2 antibodies after vaccination using kits from two manufacturers: A prospective, longitudinal, cohort study at 11 serial time points within 160 daysArticle Published on 2022-11-012022-11-15 Journal: International immunopharmacology [Category] SARS, 진단, 치료기술, [키워드] Accuracy acute respiratory syndrome Affect anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibodies antibody Antibody detection cohort study Consistency CoronaVac coronavirus COVID-19 Efficacy evaluated half-live IgG antibody IgM antibody immune response less moderate Neutralizing antibodies neutralizing antibody SARS-CoV-2 SARS-CoV-2 vaccines subject the vaccine total antibodies total antibody vaccination vaccination. Vaccine [DOI] 10.1016/j.intimp.2022.109285 PMC 바로가기
Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIVArticle Published on 2022-11-012022-11-15 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI Analysis Antibody Response CD4 CD4 cell CD4 count CD4 T-cell CD4 T-cell counts Cluster Complete COVID-19 vaccine COVID-19 vaccines determine dose evaluated Humoral response IgG IgG antibody immunization Immunosuppression impair individual log median mRNA multicentre neutralization Neutralizing antibodies Patient people living with HIV PLWH predictor Probability prospective cohort study quantitative determination receiving response to vaccination SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines Seroconversion Specific the antibody response the vaccine vaccination Vaccine vaccine. with HIV [DOI] 10.1016/j.cmi.2022.05.018 PMC 바로가기
Self-collection of capillary blood and saliva to determine COVID-19 vaccine immunogenicity in patients with immune-mediated inflammatory diseases and health professionalsArticle Published on 2022-10-142022-11-15 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 진단, [키워드] Accuracy analyzed antibodies Antibody Response being Blood blood collection both group capillary capillary blood Clinical practice collected correlation coefficient COVID-19 COVID-19 vaccine criteria determine dose effective evaluate feasibility feasible flexible Health Immune-mediated inflammatory disease less majority NPs participant Patient patient groups professional promoter protocol recorded Remote care reported Safe Saliva SARS-CoV-2 antibody response SARS-CoV-2 vaccines self-collection Self-sampling significantly significantly higher Spearman SUS telehealth. Usability vaccination Vaccination strategy Vaccine venous Wilcoxon signed-rank test [DOI] 10.3389/fpubh.2022.994770 PMC 바로가기
Recent Advances of Representative Optical Biosensors for Rapid and Sensitive Diagnostics of SARS-CoV-2Article Published on 2022-10-122022-11-15 Journal: Biosensors [Category] COVID19(2023년), SARS, 치료기술, [키워드] advance biosensor Corona COVID-19 Diagnosis diagnostic diagnostics disadvantage enhancement equipment explained high accuracy IMPROVE infected patients inherent limit operator optical optical biosensors outbreak pandemic Plasmon point-of-care point-of-care diagnostics. polymerase chain Rapid recent required Research resonance reverse transcription RT-PCR SARS-CoV-2 SARS-CoV-2 detection SARS-CoV-2 vaccines sensitive sensitivity Sensitivity and specificity SPR surface time-consuming virus [DOI] 10.3390/bios12100862 PMC 바로가기
A bivalent SARS-CoV-2 monoclonal antibody combination does not affect the immunogenicity of a vector-based COVID-19 vaccine in macaquesArticle Published on 2022-10-052022-11-15 Journal: Science Translational Medicine [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome Adenovirus Administered administration Affect approach cellular immunity coronavirus coronavirus disease COVID-19 COVID-19 vaccine cynomolgus macaques evaluate Human humoral mAb mAbs macaque monoclonal antibody monoclonal antibody combination not affect offer required SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines SARS-CoV-2 variant spike glycoprotein the vaccine Treatment vaccinated individuals vaccination rates Vaccine viral vector-based waning immunity [DOI] 10.1126/scitranslmed.abo6160 PMC 바로가기